Home/Filings/4/0001415889-23-013887
4//SEC Filing

Anand Kapila K 4

Accession 0001415889-23-013887

CIK 0001739104other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:40 PM ET

Size

13.3 KB

Accession

0001415889-23-013887

Insider Transaction Report

Form 4
Period: 2023-09-29
Transactions
  • Award

    Deferred Stock Units

    2023-09-29$11.24/sh+1,278.915$14,3755,695.173 total
    Common Stock (1,278.915 underlying)
Footnotes (3)
  • [F1]Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
  • [F2]The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
  • [F3]The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $11.24 on September 29, 2023.

Issuer

Elanco Animal Health Inc

CIK 0001739104

Entity typeother

Related Parties

1
  • filerCIK 0001679166

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:40 PM ET
Size
13.3 KB